Australia markets close in 2 hours 2 minutes

Sonnet BioTherapeutics Holdings, Inc. (SONN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.7900-0.0200 (-1.10%)
At close: 04:00PM EDT
1.8500 +0.06 (+3.35%)
After hours: 07:16PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Cash flows from operating activities
Net income
-14,459
-18,833
-29,722
-24,984
-24,265
Depreciation & amortisation
77.29
75.75
93.257
95.162
58.313
Stock-based compensation
207.014
248.626
876.368
1,375
370.055
Change in working capital
-4,538
-3,116
7.211
1,086
1,395
Accounts payable
-2,721
-2,631
971.041
1,724
168.806
Other working capital
-18,962
-21,785
-28,584
-22,556
-15,691
Other non-cash items
194
282
971.477
0.623
6,826
Net cash provided by operating activities
-18,518
-21,342
-27,774
-22,552
-15,615
Cash flows from investing activities
Investments in property, plant and equipment
-
-443.25
-810.227
-3.623
-76.183
Net cash used for investing activities
-
-443.25
-810.227
-3.623
-76.183
Cash flows from financing activities
Debt repayment
-
-0.748
0
-20.436
-110.735
Common stock issued
20,282
21,006
1,842
42,848
19,070
Other financing activities
-
-
-
-
-5,984
Net cash used provided by (used for) financing activities
20,282
21,006
4,015
42,828
23,005
Net change in cash
1,321
-778.62
-24,569
20,272
7,314
Cash at beginning of period
1,701
3,053
27,622
7,350
35.653
Cash at end of period
3,021
2,274
3,053
27,622
7,350
Free cash flow
Operating cash flow
-18,518
-21,342
-27,774
-22,552
-15,615
Capital expenditure
-
-443.25
-810.227
-3.623
-76.183
Free cash flow
-18,962
-21,785
-28,584
-22,556
-15,691